QUICK READ: Job hoppers within the pharma industry are pretty plentiful. Quitting 1–2 jobs early when you’re young is acceptable, but there are too many hoppers leaving one company for…
Investors react to irresponsible news
QUICK READ: STAT News post entitled “Early peek at data on Gilead drug suggests patients are responding to treatment” was irresponsible and had led to investors gambling on a drug…
Civil liberties vs. public health
QUICK READ: Social distancing efforts to slow the spread of the novel coronavirus are working, according to preliminary data, but there’s also a problem: There are still communities that aren’t…
Can pharma regain its reputation?
QUICK READ: Almost every pharma company is working on a treatment/vaccine for COVID-19 and some have even formed alliances with each other to speed development. If they develop new treatments…
Truth: Our health care system is a mess
QUICK READ: According to the NY Times “the American health care industry is not good at promoting health, but it excels at taking money from all of us for its…
Social media is interfering with drug development
QUICK READ: As the pandemic continues social media is playing a part in the potential approval(s) of drugs without full medical testing guidelines. Pharma companies need can earn the trust…
Will the pandemic change pharma culture?
QUICK READ: It’s going to be interesting to see how working at home changes the culture of back-to-back meetings. Will people learn that they can actually get things done without…
The failures of the CDC and FDA endangers us all
QUICK READ: The US Centers for Disease Control and Prevention has removed from its website guidelines for doctors on how to prescribe two antimalarial drugs that President Donald Trump has touted as…